Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Merck disappointed after jury undecided in Vioxx case

December 13, 2005 Sales and Marketing

Merck said it was disappointed after a jury failed to reach a unanimous decision in the first federal court case …
News

US regulator looks to improve communication strategy

December 13, 2005 Sales and Marketing

The FDA is investigating ways of improving its communication of the risks, including dangerous side-effects, linked with prescription drugs.The US …
News

Shire and New River expect new ADHD launch in 2006

December 8, 2005 Sales and Marketing

New River Pharmaceuticals has filed a new treatment for attention deficit hyperactivity disorder (ADHD) with US regulator the FDA.New River …
News

J&J submits new schizophrenia drug

December 8, 2005 Sales and Marketing

Johnson & Johnson has submitted a new schizophrenia drug to the FDA, and hopes it will succeed one of its …
News

Brooksby to be new ABPI president

December 8, 2005 Sales and Marketing

Nigel Brooksby, Sanofi-Aventis UK's managing director has been named as the ABPI's next president.Brooksby will take over from the current …
News

Merck seeks US approval for cancer vaccine

December 7, 2005 Sales and Marketing

Merck has submitted its cervical cancer vaccine Gardasil to the FDA following impressive clinical trial results against the two most …
News

Can CSOs lead the way?

December 7, 2005 Sales and Marketing

With the spotlight shining on pharma sales teams, companies are exploring a variety of ways to improve productivity and effectiveness. …
Feature

Research plans attract

December 7, 2005 Sales and Marketing

Plans to boost UK medical research through improvements to NHS systems is set to attract an extra £1 billion investment …
News

Communicating with patients

December 5, 2005 Sales and Marketing

Despite little prospect of the restrictions in Europe on communicating directly with consumers being relaxed, the issue of DTC communications …
Feature

New UK headquarters for Bristol-Myers Squibb

December 5, 2005 Sales and Marketing BMS, UK

Bristol-Myers Squibb UK has moved into a new state-of-the-art head office in Uxbridge.The £5.5 million building houses over 200 employees, …
News

Sanofi-Aventis throws its weight behind Acomplia

December 5, 2005 Sales and Marketing

Sanofi-Aventis is gearing up for the launch of its potential blockbuster Acomplia, a drug which the company wants to promote …
News

Scheuble quits as Merck KGaA chief

December 5, 2005 Sales and Marketing

Bernhard Scheuble has stepped down as chief executive of German pharma company Merck KGaA, disagreements with the company's owners thought …
News

GlaxoSmithKline’s lapatinib hailed as latest ‘wonder drug’

December 1, 2005 Sales and Marketing

GlaxoSmithKline has released new data on a number of promising new drugs in its oncology pipeline – including breast cancer …
News

Altana and Serono seeking mergers

November 30, 2005 Sales and Marketing

Two of European pharma's mid-sized companies, Serono and Altana, have separately declared their openness to takeover talks, with Pfizer and …
News

Pfizer’s new anti-smoking drug shows promise

November 29, 2005 Sales and Marketing

Smokers taking a new Pfizer treatment are more likely to kick the habit compared to those using GlaxoSmithKline's Zyban, according …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026